It is crucial to note that therapy-induced tumor cell death promotes the production of growth factors and cytokines, including WNT, EGF, TNF, IL-17, and IL-6, by cells in the TME to promote the survival of remaining tumor cells and play a role in fostering therapy resistance (Greten and Grivennikov, 2019). Here, IL17A is linked to neoplasm.